These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17721635)

  • 21. Pregnancy is more dangerous than the pill: A critical analysis of professional responses to the Yaz/Yasmin controversy.
    Geampana A
    Soc Sci Med; 2016 Oct; 166():9-16. PubMed ID: 27522113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conference highlights trends and controversies in oral contraceptive use.
    Check WA
    Clin Pharm; 1989 Nov; 8(11):752, 755, 758 passim. PubMed ID: 2805626
    [No Abstract]   [Full Text] [Related]  

  • 23. Contraceptive redesign: new progestins/new regimens.
    Sulak PJ
    J Fam Pract; 2004 Sep; Suppl():S3-8. PubMed ID: 15508356
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
    Krunic A; Ciurea A; Scheman A
    J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Debating the evidence: oral contraceptives containing drospirenone and risk of blood clots.
    Dodd S
    Curr Drug Saf; 2011 Jul; 6(3):132-3. PubMed ID: 22122386
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 28. Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke?
    Girolami A; Tezza F; Allemand E; Girolami B
    J Thromb Thrombolysis; 2008 Oct; 26(2):163-4. PubMed ID: 18157712
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient ischaemic attack associated with the new contraceptive Yasmin.
    Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
    Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychosexual well-being in women using oral contraceptives containing drospirenone.
    Nappi RE; Albani F; Tonani S; Santamaria V; Pisani C; Terreno E; Martini E; Polatti F
    Funct Neurol; 2009; 24(2):71-5. PubMed ID: 19775533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YAZ and the novel progestin drospirenone.
    Mishell DR
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Loughlin J; Seeger JD; Eng PM; Foegh M; Clifford CR; Cutone J; Walker AM
    Contraception; 2008 Nov; 78(5):377-83. PubMed ID: 18929734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presumed corneal copper deposition and oral contraceptive use.
    Orlin A; Orlin SE; Makar GA; Bunya VY
    Cornea; 2010 Apr; 29(4):476-8. PubMed ID: 20168218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central retinal artery occlusion related to ingestion of tranexamic acid].
    Dighiero P; Frau E; Bodaghi B; Labetoulle M; Offret H
    J Fr Ophtalmol; 1996; 19(12):785-6. PubMed ID: 9033905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
    Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ophthalmologic vascular occlusions and oral contraceptives].
    Asensio Sánchez VM; Pérez Flández FJ; Bartolomé Aragón A; Gil Fernández E
    Arch Soc Esp Oftalmol; 2002 Mar; 77(3):163-6. PubMed ID: 11967740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
    Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metrorrhagia caused by estrogen-progestin combinations].
    Erny R; Erny N
    Contracept Fertil Sex; 1994 Feb; 22(2):93-7. PubMed ID: 8199648
    [No Abstract]   [Full Text] [Related]  

  • 40. Yasmin and venous thromboembolism: new case reports.
    López M; Vayá A; Martínez Triguero ML; Contreras MT; Todolí J; Ricart A; Laiz B
    Clin Hemorheol Microcirc; 2009; 42(1):65-9. PubMed ID: 19363241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.